Efficacy and safety of Reyanning mixture in patients infected with SARS-CoV-2 Omicron variant: A prospective, open-label, randomized controlled trialRandomized Controlled Trial Published on 2023-01-012023-07-10 Journal: Phytomedicine : international journal of phytother [Category] COVID19(2023년), [키워드] Coronavirus disease 2019 omicron Randomized controlled trial Reyanning mixture severe acute respiratory syndrome coronavirus 2 traditional Chinese medicine. [DOI] 10.1016/j.phymed.2022.154514 PMC 바로가기 [Article Type] Randomized Controlled Trial
Assessing the reporting quality of randomized controlled trials on COVID-19 vaccines: a systematic reviewCOVID-19 백신에 대한 무작위 대조 시험의 보고 품질 평가: 체계적인 검토Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] 임상, [키워드] adverse effect Analysis analysis of variance Assessing CONSORT CONSORT statement controlled trials COVID-19 COVID-19 vaccine COVID-19 vaccines criteria current database effective evaluated Evidence groups independent indicate indicated median Mortality no significant difference predicted Randomized Randomized controlled trial Randomized controlled trials RCT RCTs reported Reporting Reporting quality review. Standard systematic review Univariate analysis variance variety [DOI] 10.1080/21645515.2022.2031453 PMC 바로가기 [Article Type] Article
Effect of positive event recording based on positive psychology on healthy behaviors and readmission rate of patients after PCI: a study protocol for a prospective, randomized controlled trialArticle Published on 2022-12-132023-07-11 Journal: Trials [Category] COVID19(2023년), [키워드] behaviors Coronary heart disease positive Randomized controlled trial Readmission rate. [DOI] 10.1186/s13063-022-06964-9 PMC 바로가기
Oman’s COVID-19 publication trends: A cross-sectional bibliometric studyResearch article Published on 2022-12-012022-10-05 Journal: Public Health in Practice [Category] 임상, [키워드] access article articles bibliometric analysis carried clinician COVID-19 COVID-19 pandemic COVID-19 research cross-sectional defined dissemination Factor Google Scholar Health International knowledge Meta-analysis National objective Oman produced Public Randomized controlled trial Research researcher researchers retrieved scientometric [DOI] 10.1016/j.puhip.2022.100310 [Article Type] Research article
Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trialArticle Published on 2022-11-082022-11-16 Journal: Trials [Category] SARS, 변종, [키워드] adaptive anti-COVID-19 IVIG antivirals clinical evidence clinical trial collected convalescent convalescent plasma COVID-19 cumulative death Efficacy eligibility criteria evaluate Health hyperimmune immunization immunomodulators intravenous Intravenous immunoglobulin low dose monoclonal antibodies Neutralizing non-specific novel Novel coronavirus outcome Passive passive immunization Patient phase Pneumonia polyclonal polyclonal antibodies Pooled convalescent plasma Potential treatment Randomized Randomized controlled trial receive Recovered COVID-19 patients reported SARS CoV-2 SARS CoV-2. SARS-CoV-2 sealed Secondary outcomes severe COVID-19 severe COVID-19 patient severe COVID-19 patients Standard of care Steroids Study protocol therapeutic option therapy treat Treatment Trial variant variants of concern virus virus particles World Health Organization [DOI] 10.1186/s13063-022-06860-2 PMC 바로가기
Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasiaArticle Published on 2022-11-072022-11-16 Journal: Orphanet Journal of Rare Diseases [Category] 유전자 메커니즘, [키워드] analysis Angiogenesis assigned Biomarkers bleeding Blood center double-blind doxycycline Effectiveness ENG Epistaxis Frequency heart failure help hemorrhage Hemorrhagic Hereditary Hereditary hemorrhagic telangiectasia Hereditary hemorrhagic telangiectasia. HHT IL-6 Inflammatory intravenous limitations Liver disease malformation marker mechanism Michael morbidity no significant difference not significantly different observation pathway Patient Placebo placebo-controlled provided Quality of life Randomized controlled trial Randomly RBC recruited Registered Registration secondary significantly higher stroke telangiectasia therapy Toronto Treatment treatment period Trial VEGF [DOI] 10.1186/s13023-022-02539-8 PMC 바로가기
Cross-cultural comparison of nudging effects for environmental protection: A case-study of risk-averse attitudes toward disposable plasticsArticle Published on 2022-11-032022-11-16 Journal: PLoS ONE [Category] 비임상, [키워드] Analysis attribute benefit Canada caused conducted contributed correlated country COVID-19 cross-cultural Effect effect size effective Effects Factors identify IMPROVE individual information intervention effect Japan limit Linear regression model Machiavellianism positive attitude Randomized controlled trial risk significant effect suggested Support threat traits variety were measured [DOI] 10.1371/journal.pone.0277183 PMC 바로가기
An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: A randomized controlled trial (CVIM 4 study)Article Published on 2022-11-012022-11-15 Journal: American journal of transplantation : official jou [Category] COVID19(2023년), SARS, 진단, [키워드] age anti-RBD antibody B cell response BNT162b2 booster Cell-mediated immunity ChAdOx1 ChAdOx1 nCoV-19 comparable Coronavirus disease 2019 COVID-19 COVID-19 vaccine dose elicit group humoral immunization Immunocompromised immunogenicity investigated IQR kidney transplant male median mononuclear cells mRNA mRNA-1273 mRNA-1273. no difference participant Peripheral blood positive Randomized Randomized controlled trial receive recipients response SARS-CoV-2 seroconversion rate significantly statistically T cell Vaccine Viral vector virus neutralization test [DOI] 10.1111/ajt.17151 PMC 바로가기
Traditional Chinese medicine combined with Moxibustion in the treatment of “long-COVID”: A protocol for systematic review and meta-analysisArticle Published on 2022-10-282022-11-16 Journal: Medicine [Category] meta-analysis, [키워드] benefit carried China Chinese composed COVID-19 database Efficacy and safety eight evaluate evaluated Evidence exclusion criteria Inclusion Infrastructure international public health journal knowledge lack Meta-analysis moxibustion patients with COVID-19 prevalent protocol Randomized controlled trial Research risk Science screened symptoms of COVID-19 systematic review technology Traditional Chinese medicine treat Treatment was used Web of Science [DOI] 10.1097/MD.0000000000031447 PMC 바로가기
Acupuncture for dry eye disease after recovery from COVID-19: A protocol for systematic review and meta-analysisArticle Published on 2022-10-282022-11-16 Journal: Medicine [Category] meta-analysis, [키워드] acupuncture Chinese clinical decision Cochrane Library coronavirus disease COVID-19 COVID-19 infection COVID-19 patient database disease Diseases Dry eye Efficacy and safety evaluate evaluated exclusion criteria Guidance Inclusion Infrastructure Meta-analysis ophthalmic Patient peer-reviewed Prevalence protocol Randomized controlled trial RCT review risk Science screened Stata Symptom systematic review technology Treatment was performed was used Web of Science [DOI] 10.1097/MD.0000000000031234 PMC 바로가기